News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Amer Zeidan Reflects on Anticipation for VERONA Trial Results in High-Risk MDS
Amer Zeidan/yalemedicine.org
May 23, 2025, 06:26

Amer Zeidan Reflects on Anticipation for VERONA Trial Results in High-Risk MDS

Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, posted on X:

“The entire MDS is anxiously waiting for the results of the randomized Phase 3 VERONA trial of azacitidine + venetoclax versus azacitidine-+Placebo in patients with higher risk MDS with the primary endpoint of overall survival, what do you expect the results to be?”

Amer Zeidan invited responses on expectations for the VERONA trial results in higher-risk MDS patients. He offered four answer options: positive, negative, too close to guess, or I don’t manage MDS.

More posts about MDS on OncoDaily.

Amer Zeidan cancer MDS OncoDaily Oncology VERONA trial
Special Coverage
Blog
May 23, 2025, 06:26
Amer Zeidan Reflects on Anticipation for VERONA Trial Results in High-Risk MDS
Blog
May 23, 2025, 06:17
Join ASCO for the Social Media Meetup
Blog
May 23, 2025, 06:09
Stephen V Liu: Atezolizumab Plus Bevacizumab and Chemotherapy in Metastatic Nonsquamous NSCLC
Blog
May 23, 2025, 04:26
Angela Casini: Proud to See Our Radiopharmaceuticals Work Featured in Nature Biotechnology
Blog
May 23, 2025, 02:43
Richard Horton: This Year Is One of the Most Important for NCDs
Career
May 23, 2025, 01:50
Khalid El Bairi: Proud to See Aya Ikhelk Win Best Oral Presentation Award
Blog
May 22, 2025, 23:24
Aaron Sverdlov: Synergy in Cardio-Oncology China Visit Was a Fantastic Experience
Blog
May 22, 2025, 17:38
Zacharoula Sidiropoulou: Are the Treatments We Prescribe to Our Most Vulnerable Patients Actually Tested On Them?
Blog
May 22, 2025, 17:32
Join Wide-angle in Oncology: Pediatric Oncology and Hematology Webinar by AIEOP
Blog
May 22, 2025, 17:25
Olubukola Ayodele Advocates for Insurance Reform for Cancer Survivors
Blog
May 22, 2025, 16:59
Lung Cancer Network Malaysia Launches Nation’s First Ever Clinical Practice Guidelines For Lung Cancer
Career
May 22, 2025, 16:54
A huge congratulations to Emily Mould for her selection for the 2025 cohort of the WILD Program - Children's Cancer Institute